We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-7.92%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$8.14B
AUM Growth
+$473M
Cap. Flow
+$1.3B
Cap. Flow %
15.91%
Top 10 Hldgs %
18.35%
Holding
1,253
New
376
Increased
261
Reduced
225
Closed
366

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$180M
2
ZTS icon
Zoetis
ZTS
+$103M
3
GILD icon
Gilead Sciences
GILD
+$98.1M
4
SHW icon
Sherwin-Williams
SHW
+$85.9M
5
VZ icon
Verizon
VZ
+$79.9M

Sector Composition

Rank Sector Weight
1 Healthcare 23.21%
2 Financials 15.39%
3 Communication Services 14.58%
4 Consumer Discretionary 9.63%
5 Industrials 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KG
451
Kestrel Group
KG
$68.6M
$2.04M 0.03%
+7,340
New +$2.25M
ROST icon
452
Ross Stores
ROST
$81.7B
$2.03M 0.03%
+41,961
New +$2.14M
MANH icon
453
Manhattan Associates
MANH
$11.4B
$2.01M 0.02%
+32,218
New +$2.01M
CLR
454
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$2.01M 0.02%
69,271
+15,810
+30% +$514K
ABBV icon
455
AbbVie
ABBV
$433B
$1.99M 0.02%
36,599
-900
-2% -$58.6K
FANG icon
456
Diamondback Energy
FANG
$52.5B
$1.98M 0.02%
30,719
+22,191
+260% +$1.51M
ETR icon
457
Entergy
ETR
$50.1B
$1.98M 0.02%
+60,780
New +$2.06M
FLXN
458
DELISTED
Flexion Therapeutics, Inc.
FLXN
$1.98M 0.02%
+132,945
New +$3.12M
UNF icon
459
Unifirst Corp
UNF
$5.24B
$1.97M 0.02%
18,484
-8,226
-31% -$916K
WBMD
460
DELISTED
WebMD Health Corp.
WBMD
$1.96M 0.02%
+49,286
New +$2.08M
TEP
461
DELISTED
Tallgrass Energy Partners, LP
TEP
$1.93M 0.02%
+49,077
New +$2.21M
SPNT icon
462
SiriusPoint
SPNT
$2.69B
$1.92M 0.02%
+143,058
New +$2.04M
DMK
463
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$1.92M 0.02%
6,959
RAI
464
DELISTED
Reynolds American Inc
RAI
$1.91M 0.02%
+43,110
New +$1.79M
GOOG icon
465
Alphabet (Google) Class C
GOOG
$4.32T
$1.9M 0.02%
62,560
-4,453,920
-99% -$137M
EQM
466
DELISTED
EQM Midstream Partners, LP
EQM
$1.9M 0.02%
28,673
-138,876
-83% -$10.5M
NVO
467
Novo Nordisk
NVO
$207B
$1.86M 0.02%
+68,646
New +$1.94M
MATX icon
468
Matsons
MATX
$6.18B
$1.86M 0.02%
+48,290
New +$1.91M
DAR icon
469
Darling Ingredients
DAR
$9.54B
$1.86M 0.02%
165,158
+33,058
+25% +$422K
PKG icon
470
Packaging Corp of America
PKG
$22.8B
$1.85M 0.02%
+30,823
New +$2.06M
WEC icon
471
WEC Energy
WEC
$35.2B
$1.85M 0.02%
+35,356
New +$1.72M
APTV icon
472
Aptiv
APTV
$10.1B
$1.84M 0.02%
24,217
+1,944
+9% +$149K
AIV
473
Aimco
AIV
$384M
$1.83M 0.02%
+372,052
New +$1.88M
ALSN icon
474
Allison Transmission
ALSN
$9.72B
$1.82M 0.02%
+68,235
New +$1.95M
NEOS
475
DELISTED
Neos Therapeutics, Inc
NEOS
$1.81M 0.02%
+86,233
New +$1.9M

Similar funds

Marshall Wace's Q3 2015 Portfolio in Review

As of Q3 2015, Marshall Wace held 1,253 positions worth $8.14B, up 6.2% from $7.67B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace deployed $1.3B of net new capital in Q3 2015, opening 376 new positions and adding to 261 existing holdings. Its largest new stake was Alphabet (Google) Class A: 5,575,920 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $137M trimmed.

  • Marshall Wace's largest Q3 2015 buy was Alphabet (Google) Class A: 5,575,920 shares worth $178M.
  • Marshall Wace added most to Zoetis in Q3 2015, an estimated $103M increase.
  • Marshall Wace's biggest Q3 2015 reduction was Alphabet (Google) Class C, cutting an estimated $137M.
  • Marshall Wace fully exited Emerson Electric in Q3 2015, selling an estimated $46.3M.
  • Marshall Wace's ten largest holdings make up 18% of its $8.14B portfolio in Q3 2015.
  • Marshall Wace opened 376 new positions and closed 366 in Q3 2015.
  • Marshall Wace's portfolio value rose 6.2% quarter-over-quarter to $8.14B.

Based on Marshall Wace's 13F filing for Q3 2015, filed 12 Nov 2015.